Speech by CS at 13th Hong Kong Allergy Convention Opening Ceremony (English just) (with photos/video)
******************************************************************************************
Following is the speech by the Chief Secretary for Administration, Mr Chan Kwok-ki, at the 13th Hong Kong Allergy Convention Opening Ceremony today (October 18):
Dr Philip Li (President of Hong Kong Institute of Allergy), Professor Gary Wong (President-Elect of World Allergy Organization), differentiated visitors, girls and gentlemen,
Great afternoon. It is an enjoyment to sign up with the opening event of the 13th Hong Kong Allergy Convention.
This biennial medical event has actually ended up being an extremely expected occasion, in your area, regionally and globally. Considering that it started over twenty years earlier, the Convention has actually united world specialists in allergic reaction. It assists advance understanding, share finest practices and influence development in allergic reaction and immunology.
For that, my thanks to the Hong Kong Institute of Allergy, and its vital work over these previous 29 years, promoting allergic reaction as a specialized, supporting research study and arranging occasions like this two-day global event.
This year’s Convention style, “Allergy Beyond Borders”advises us of our shared objective– to cross geographical and institutional barriers for much better allergic reaction care worldwide.
Allergic illness have actually ended up being amongst the most typical illness worldwide. In Hong Kong, some 400 000 clients are being dealt with for food allergic reactions alone.
And, as you are aware, allergic reactions understand no borders. Enable me to touch on a few of the research study locations we’re working on in Hong Kong.
In 2021, we developed the Hong Kong Genome Institute. Its very first significant job, the Hong Kong Genome Project, has actually hired more than 47 000 individuals to construct a genomic database concentrated on the South China population, developing a collective platform for scientists, academics and organizations, speeding up medical trials and drug advancements.
We are likewise accelerating scientific trials and brand-new drug approvals.
The Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone, supporting the collaborated I&T advancement of Hong Kong and Shenzhen, promotes biomedical innovation.
It speeds up the examination, examination and scientific trials of drugs and medical gadgets in positioning with worldwide requirements.
We’ve likewise developed the Greater Bay Area International Clinical Trial Institute, offering one-stop scientific trial assistance.
Before year’s end, we will develop a brand-new partnership platform with Shenzhen to offer assessment, matching and recommendation services for medical research study organisations carrying out scientific trials in Hong Kong and the Greater Bay Area.
We’re reforming drug approvals, too. Through the “1+” system, drug business just require approval from one referral drug authority to obtain registration in Hong Kong. That is, naturally, if they are supported by regional scientific information and their scope of application is identified by pertinent regional specialists.
Last month’s Policy Address vowed to accelerate the “1+” system, piloting concern assessment of ingenious drugs suggested by the Hospital Authority for extreme or uncommon illness.
Ladies and gentlemen, there’s much to anticipate over these next 2 days. And my thanks, when again, to the Hong Kong Institute of Allergy for arranging this year’s Allergy Convention. I’m likewise grateful to different organisations supporting the Convention.
I want you a fulfilling Convention and the very best of medical research study and health in the coming year. And for those joining us from abroad, delight in a remarkable remain in Hong Kong, Asia’s world city.
Thank you.